v3.24.0.1
SHAREHOLDER'S CAPITAL - RSU and DSU Activity (Details)
 12 Months Ended
Dec. 31, 2023
Option
$ / shares
shares
RSUs  
Disclosure Of Other Equity Instruments In Share-Based Payment Arrangement [Line Items]  
Number of other equity instruments outstanding at beginning of period | Option 1,906,769
Number of other equity instruments granted | Option 2,581,840
Number of other equity instruments settled | Option (2,050,551)
Number of other equity instruments forfeited | Option (109,416)
Number of other equity instruments cancelled | shares (16,881)
Number of other equity instruments outstanding at end of period | Option 2,311,761
Number of other equity instruments expected to vest | Option 2,125,322
Weighted average exercise price of other equity instruments outstanding at beginning of period (US$ per share) $ 28.10
Weighted average exercise price of other equity instruments granted (US$ per share) 31.30
Weighted average exercise price of other equity instruments settled (US$ per share) 29.03
Weighted average exercise price of other equity instruments forfeited (US$ per share) 30.03
Weighted average exercise price of other equity instruments cancelled (US$ per share) 30.25
Weighted average exercise price of other equity instruments outstanding at end of period (US$ per share) 30.74
Weighted average exercise price of other equity instruments vested and expected to vest (US$ per share) $ 30.63
DSUs  
Disclosure Of Other Equity Instruments In Share-Based Payment Arrangement [Line Items]  
Number of other equity instruments outstanding at beginning of period | Option 60,960
Number of other equity instruments granted | Option 29,573
Number of other equity instruments outstanding at end of period | Option 90,533
Number of other equity instruments expected to vest | Option 90,533
Weighted average exercise price of other equity instruments outstanding at beginning of period (US$ per share) $ 28.50
Weighted average exercise price of other equity instruments granted (US$ per share) 33.14
Weighted average exercise price of other equity instruments outstanding at end of period (US$ per share) 30.02
Weighted average exercise price of other equity instruments vested and expected to vest (US$ per share) $ 30.02